Aslan Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Aslan Pharmaceuticals (ASLN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Aslan Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Aslan Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Aslan Pharmaceuticals by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $326k | 625k | 0.52 |
2023-06-30 | $365 | 100 | 3.65 |